Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8285171rdf:typepubmed:Citationlld:pubmed
pubmed-article:8285171lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0278348lld:lifeskim
pubmed-article:8285171lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8285171pubmed:issue12lld:pubmed
pubmed-article:8285171pubmed:dateCreated1994-2-17lld:pubmed
pubmed-article:8285171pubmed:abstractTextWe established constitutively an interferon-gamma (IFN-gamma) producing cell line (MBT2/gamma) from a mouse bladder cancer cell line (MBT2) by retroviral transfer of a mouse IFN-gamma cDNA. Although the in vitro cell growth of these cells was unaffected by the IFN-gamma production, their subcutaneous tumor growth in syngeneic C3H/He mice was different; MBT2/gamma tumor growth was more strongly suppressed (3/20) than that of MBT2 (10/10). MBT2/gamma tumor growth was observed in nude mice (6/6). The mice immunized with MBT2/gamma were resistant to tumor growth of the parental cells (7/9; 77%), but permitted the growth of another kind of C3H/He tumor line. These findings indicate that the reduced tumorigenicity of the IFN-gamma producing line was due to the augmented specific antitumor immunity, probably as a result of the immunomodulatory effects of the IFN-gamma derived from the tumor.lld:pubmed
pubmed-article:8285171pubmed:languagejpnlld:pubmed
pubmed-article:8285171pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285171pubmed:citationSubsetIMlld:pubmed
pubmed-article:8285171pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8285171pubmed:statusMEDLINElld:pubmed
pubmed-article:8285171pubmed:monthDeclld:pubmed
pubmed-article:8285171pubmed:issn0018-1994lld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:WatanabeYYlld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:TeramuraYYlld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:KuribayashiKKlld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:YoshidaOOlld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:HiuraMMlld:pubmed
pubmed-article:8285171pubmed:authorpubmed-author:HashimuraTTlld:pubmed
pubmed-article:8285171pubmed:issnTypePrintlld:pubmed
pubmed-article:8285171pubmed:volume39lld:pubmed
pubmed-article:8285171pubmed:ownerNLMlld:pubmed
pubmed-article:8285171pubmed:authorsCompleteYlld:pubmed
pubmed-article:8285171pubmed:pagination1205-8lld:pubmed
pubmed-article:8285171pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:meshHeadingpubmed-meshheading:8285171-...lld:pubmed
pubmed-article:8285171pubmed:year1993lld:pubmed
pubmed-article:8285171pubmed:articleTitle[Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene].lld:pubmed
pubmed-article:8285171pubmed:affiliationDepartment of Urology, Faculty of Medicine, Kyoto University.lld:pubmed
pubmed-article:8285171pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8285171pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:8285171pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed